There’s an easy way to see your chances of having a heart attack, years—even decades—before it happens. Think of it like a ...

Paula Vanderpluym's smartwatch may look like a small part of her wardrobe, but to a team of researchers in Toronto, it ...

As the number of people living with long COVID continues to grow, understanding its broader health consequences will be ...

People whose sleep apnea changes dramatically from night to night are 30% more likely to have a heart attack, stroke, or ...

Nationally, there has been a rise in the number of children and adolescents with congenital and acquired heart disease ...

The incidence and prevalence of heart failure with preserved ejection fraction (HFpEF) is increasing, along with the aging population and the ongoing rise in risk factors such as hypertension, ...

Acorai is pleased to announce the enrolment of its first patient in the 1000-patient HOSP-HF study (Hemodynamic Observational Study in Patients with Heart Failure using a Non-Invasive Multi-Modal ...

AI is transforming cardiovascular care by enabling early detection, accurate diagnosis and better risk assessment of heart failure patients ...

Treatment management guided by the use of a noninvasive device to monitor fluid accumulation in the lungs substantially reduced hospitalizations and deaths among patients with heart failure with ...

The first randomized trial to compare standard percutaneous coronary intervention (PCI), also known as coronary angioplasty, with PCI accompanied by the use of a temporary, miniaturized pump to ...

A person with advanced heart failure can look stable at a routine clinic visit. Their vitals may not alarm anyone. Their ultrasound might appear unremarkable to a quick review. The most revealing ...

Oral semaglutide reduces the risk for a composite heart failure outcome, including hospitalization and cardiovascular death, in patients with preexisting heart failure. Oral semaglutide reduces risk ...